3.0-T intraoperative magnetic resonance imaging-guided resection in cerebral glioma surgery: Interim analysis of a prospective, randomized, triple-blind, parallel-controlled trial

Neurosurgery

Volumn 61, Issue , 2007, Pages 145-154

  Wu, Jin Song ^a   Gong, Xiu ^b   Song, Yan Yan ^c   Zhuang, Dong Xiao ^a   Yao, Cheng Jun ^a   Qiu, Tian Ming ^a   Lu, Jun Feng ^a   Zhang, Jie ^b   Zhu, Wei ^a   Mao, Ying ^a   Zhou, Liang Fu ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TEMOZOLOMIDE;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONFERENCE PAPER; CONTROLLED STUDY; EVIDENCE BASED PRACTICE; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; IMAGING SOFTWARE; INTERIM ANALYSIS; INTERVENTION STUDY; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; LANGUAGE DELAY; LANGUAGE DISABILITY; MALE; METHODOLOGY; MORBIDITY; MOTOR DYSFUNCTION; MULTIMODALITY CANCER THERAPY; NEURONAVIGATION; NUCLEAR MAGNETIC RESONANCE SCANNER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; TRIPLE BLIND PROCEDURE; BRAIN NEOPLASMS; COMPUTER ASSISTED SURGERY; INTRAOPERATIVE PERIOD; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARALLEL DESIGN; PROCEDURES; PROPORTIONAL HAZARDS MODEL; SURGERY; TUMOR VOLUME;

ADULT; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; METHODS; MIDDLE AGED; MORTALITY; NEURONAVIGATION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURGERY; SURGERY, COMPUTER-ASSISTED;

EID: 84964284449     PISSN: 0148396X     EISSN: 15244040     Source Type: Journal    
DOI: 10.1227/NEU.0000000000000372     Document Type: Conference Paper

References (38)

1. Acevedo CV, Vinas FC, Dujovny M. Intraoperative use of magnetic resonance imaging: neurosurgical applications and technical limitations. Crit Rev Neurosurg. 1999;9(5):279-286.
2. Black PM, Moriarty T, Alexander E III, et al. Development and implementation of intraoperative magnetic resonance imaging and its neurosurgical applications. Neurosurgery. 1997;41(4):831-842; discussion 842-845.
3. Alexander E III, Moriarty TM, Kikinis R, Jolesz FA. Innovations in minimalism: intraoperative MRI. Clin Neurosurg. 1996;43:338-352.
4. Schwartz RB, Hsu L, Wong TZ, et al. Intraoperative MR imaging guidance for intracranial neurosurgery: experience with the first 200 cases. Radiology. 1999;211 (2):477-488.
5. Fahlbusch R, Ganslandt O, Nimsky C. Intraoperative imaging with open magnetic resonance imaging and neuronavigation. Childs Nerv Syst. 2000;16 (10-11):829-831.
6. Nimsky C, Ganslandt O, Cerny S, Hastreiter P, Greiner G, Fahlbusch R. Quantification of, visualization of, and compensation for brain shift using intraoperative magnetic resonance imaging. Neurosurgery. 2000;47(5):1070-1079; discussion 1079-1080.
7. Wirtz CR, Knauth M, Staubert A, et al. Clinical evaluation and follow-up results for intraoperative magnetic resonance imaging in neurosurgery. Neurosurgery. 2000;46(5):1112-1120; discussion 1120-1122.
8. Schulder M, Liang D, Carmel PW. Cranial surgery navigation aided by a compact intraoperative magnetic resonance imager. J Neurosurg. 2001;94(6):936-945.
9. Nimsky C, Ganslandt O, Buchfelder M, Fahlbusch R. Glioma surgery evaluated by intraoperative low-field magnetic resonance imaging. Acta Neurochir Suppl. 2003;85:55-63.
10. Schulder M, Carmel PW. Intraoperative magnetic resonance imaging: impact on brain tumor surgery. Cancer Control. 2003;10(2):115-124.
11. Nimsky C, Fujita A, Ganslandt O, Von Keller B, Fahlbusch R. Volumetric assessment of glioma removal by intraoperative high-field magnetic resonance imaging. Neurosurgery. 2004;55(2):358-370; discussion 370-371.
12. Muragaki Y, Iseki H, Maruyama T, et al. Usefulness of intraoperative magnetic resonance imaging for glioma surgery. Acta Neurochir Suppl. 2006;98:67-75.
13. Kubben PL, ter Meulen KJ, Schijns OE, ter Laak-Poort MP, van Overbeeke JJ, van Santbrink H. Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review. Lancet Oncol. 2011;12(11):1062-1070.
14. Nimsky C. Intraoperative MRI in glioma surgery: proof of benefit? Lancet Oncol. 2011;12(11):982-983.
15. Senft C, Bink A, Franz K, Vatter H, Gasser T, Seifert V. Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol. 2011;12(11):997-1003.
16. Lu J, Wu J, Yao C, et al. Awake language mapping and 3-Tesla intraoperative MRI-guided volumetric resection for gliomas in language areas. J Clin Neurosci. 2013;20(9):1280-1287.
17. Qiu TM, Yao CJ, Wu JS, et al. Clinical experience of 3T intraoperative magnetic resonance imaging integrated neurosurgical suite in Shanghai Huashan Hospital. Chin Med J (Engl). 2012;125(24):4328-4333.
18. Wu JS, Zhang J, Zhuang DX, et al. Current status of cerebral glioma surgery in China. Chin Med J (Engl). 2011;124(17):2569-2577.
19. Claus EB, Horlacher A, Hsu LG, et al. Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer. 2005;103 (6):1227-1233.
20. Kuhnt D, Becker A, Ganslandt O, Bauer M, Buchfelder M, Nimsky C. Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. Neuro Oncol. 2011;13(12):1339-1348.
21. Brem SS, Bierman PJ, Brem H. NCCN Clinical Practice Guidelines in Oncology-v.2.2011: Central Nervous System Cancers. 2011. Available at: www.nccn.org. Accessed December 8, 2011.
22. Vogelbaum MA, Jost S, Aghi MK, et al. Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group. Neurosurgery. 2012;70(1):234-243; discussion 243-244.
23. Wen PY, Macdonald DR, Reardon DA, et al. Updated response assessment criteria for high-grade gliomas: Response Assessment in Neuro-Oncology Working Group. J Clin Oncol. 2010;28(11):1963-1972.
24. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95(2):190-198.
25. Sanai N, Polley MY, Berger MS. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression. J Neurosurg. 2010;112(1):1-9.
26. Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg. 2011;115(1): 3-8.
27. Smith JS, Chang EF, Lamborn KR, et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol. 2008;26 (8):1338-1345.
28. Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008;62(4):753-764; discussion 764-766.
29. Sanai N, Berger MS. Extent of resection influences outcomes for patients with gliomas. Rev Neurol (Paris). 2011;167(10):648-654.
30. Sanai N, Chang S, Berger MS. Low-grade gliomas in adults. J Neurosurg. 2011;115 (5):948-965.
31. McGirt MJ, Chaichana KL, Attenello FJ, et al. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery. 2008;63(4):700-708.
32. Stummer W, Reulen HJ, Meinel T, et al. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery. 2008;62(3):564-576; discussion 564-576.
33. Wu JS, Lu JF, Gong X, Mao Y, Zhou LF. Neuronavigation surgery in China: reality and prospects. Chin Med J (Engl). 2012;125(24):4497-4503.
34. Wu JS, Zhou LF, Tang WJ, et al. Clinical evaluation and follow-up outcome of diffusion tensor imaging-based functional neuronavigation: a prospective, controlled study in patients with gliomas involving pyramidal tracts. Neurosurgery. 2007;61(5):935-948; discussion 948-949.
35. Zhu FP, Wu JS, Song YY, et al. Clinical application of motor pathway mapping using diffusion tensor imaging tractography and intraoperative direct subcortical stimulation in cerebral glioma surgery: a prospective cohort study. Neurosurgery. 2012;71(6):1170-1184.
36. Pichlmeier U, Bink A, Schackert G, Stummer W. Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol. 2008;10(6):1025-1034.
37. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. Fluorescenceguided surgery with 5-aminolevulinic acid for resection ofmalignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006;7(5):392-401.
38. Beiko J, Suki D, Hess KR, et al. IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection. Neuro Oncol. 2014;16(1):81-91.